Journal
HUMAN IMMUNOLOGY
Volume 66, Issue 4, Pages 364-370Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2005.01.032
Keywords
desensitization; plasmapheresis; IVIg; donor-specific antibody
Categories
Ask authors/readers for more resources
Antibody to donor HLA antigens is a significant barrier to both access to and outcome of allogeneic transplants. Many attempts have been made to desensitize patients with HLA-specific antibody, but the most effective and durable have been treatment with high-dose pooled human intravenous immunoglobulin (lVIg) and a combination of plasmapheresis and low-dose IVIg. Despite the success of these treatments, low levels of donor-specific antibody (DSA) persist in some patients. We examined factors that may be related to and used to predict the elimination of DSA. The most significant associations have been strength of antibody at initiation of treatment and antibody specificity, although other factors revealed a trend toward association. We demonstrate how the types of data generated here can be used to predict elimination or persistence of DSA. (c) American Society for Histocompatibility and Immunogenetics, 2005. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available